FDA disappointed with slow uptake of approvals for stem cell therapies
Regulatory NewsJoanne S. Eglovitch.jpg.aspx?lang=en-us&width=380&height=573&ext=.jpg)
Biologics/ biosimilars/ vaccinesBiotechnologyComplianceNorth AmericaRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyComplianceNorth AmericaRegulatory Intelligence/Policy